Early Intratracheal Budesonide Didn't Improve Outcomes for Preterm Infants

(MedPage Today) -- In extremely preterm infants receiving surfactant, early intratracheal budesonide had little to no effect on survival free of bronchopulmonary dysplasia (BPD), a randomized clinical trial found.
Among 1,059 infants, survival...